George Baltatzis

Dr. George Baltatzis

National and Kapodistrian University of Athens, Athens, Attikí, Greece

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AVAna Virgolino
Ana Virgolino
OSOsvaldo Santos
Osvaldo Santos
JCJoana Costa
Joana Costa
MFMónica Fialho
Mónica Fialho
Ivo IavicoliIvo Iavicoli
Ivo Iavicoli
UFUlrike Fiddicke
Ulrike Fiddicke
The increasing number of human biomonitoring (HBM) studies undertaken in recent decades has brought to light the need to harmonise procedures along all phases of the study, including sampling, data collection and analytical methods to allow data comparability. The first steps towards harmonisation are the identification and collation of HBM methodological information of existing studies and data gaps. Systematic literature reviews and meta-analyses have been traditionally put at the top of the hierarchy of evidence, being increasingly applied to map available evidence on health risks linked to exposure to chemicals. However, these methods mainly capture peer-reviewed articles, failing to comprehensively identify other important, unpublished sources of information that are pivotal to gather a complete map of the produced evidence in the area of HBM. Within the framework of the European Human Biomonitoring Initiative (HBM4EU) initiative—a project that joins 30 countries, 29 from Europe plus Israel, the European Environment Agency and the European Commission—a comprehensive work of data triangulation has been made to identify existing HBM studies and data gaps across countries within the consortium. The use of documentary analysis together with an up-to-date platform to fulfil this need and its implications for research and practice are discussed.

14 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
DCDimitrios Chioureas
Dimitrios Chioureas
JBJanina Beck
Janina Beck
GBGeorge Baltatzis
George Baltatzis
IVIoulia Vardaki
Ioulia Vardaki
PFPedro Fonseca
Pedro Fonseca
Theocharis PanaretakisTheocharis Panaretakis
Theocharis Panaretakis
The oncogenic pathways activated by the NPM-ALK chimeric kinase of ALK+ anaplastic large cell lymphoma (ALCL) are well characterized; however, the potential interactions of ALK signaling with the microenvironment are not yet known. Here we report that ALK+ ALCL-derived exosomes contain critical components of ALK signaling as well as CD30, and that exosome uptake by lymphoid cells led to increased proliferation and expression of critical antiapoptotic proteins by the recipient cells. The bone marrow fibroblasts highly uptake ALK+ ALCL-derived exosomes and acquire a cancer-associated fibroblast (CAF) phenotype. Moreover, exosome-mediated activation of stromal cells altered the cytokine profile of the microenvironment. These interactions may contribute to tumor aggressiveness and possibly resistance to treatment.